{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:58:09Z","timestamp":1791655089146,"version":"4.3.4"},"reference-count":35,"publisher":"Microbiology Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1099\/jmm.0.000897","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T16:13:05Z","timestamp":1547827985000},"page":"480-492","source":"Crossref","is-referenced-by-count":28,"title":["Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection"],"prefix":"10.1099","volume":"68","author":[{"given":"Yuhang","family":"Dong","sequence":"first","affiliation":[{"name":"1\u200bDepartment of Microbiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Ma","sequence":"additional","affiliation":[{"name":"1\u200bDepartment of Microbiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"1\u200bDepartment of Microbiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qikang","family":"Ying","sequence":"additional","affiliation":[{"name":"1\u200bDepartment of Microbiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Han","sequence":"additional","affiliation":[{"name":"2\u200bNo. 1 Cadet Brigade, Fourth Military Medical University, Xi'an, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"2\u200bNo. 1 Cadet Brigade, Fourth Military Medical University, Xi'an, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjin","family":"Yang","sequence":"additional","affiliation":[{"name":"2\u200bNo. 1 Cadet Brigade, Fourth Military Medical University, Xi'an, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[{"name":"2\u200bNo. 1 Cadet Brigade, Fourth Military Medical University, Xi'an, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"1\u200bDepartment of Microbiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Liu","sequence":"additional","affiliation":[{"name":"1\u200bDepartment of Microbiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingan","family":"Wu","sequence":"additional","affiliation":[{"name":"1\u200bDepartment of Microbiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/ilar\/ilx034","article-title":"The impact of global environmental changes on infectious disease emergence with a focus on risks for Brazil","volume":"58","author":"Nava","year":"2017","journal-title":"Ilar J"},{"key":"R2","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4255","article-title":"Spatial and temporal patterns of human Puumala virus (PUUV) infections in Germany","volume":"6","author":"Cunze","year":"2018","journal-title":"PeerJ"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-976491"},{"key":"R4","first-page":"1","article-title":"Hemorrhagic fever with renal syndrome: pathogenesis and clinical picture","volume":"6","author":"Jiang","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"R5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/CMR.00062-09","article-title":"A global perspective on hantavirus ecology, epidemiology, and disease","volume":"23","author":"Jonsson","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"R6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3201\/eid1608.090470","article-title":"Hantavirus infections in humans and animals, China","volume":"16","author":"Zhang","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"R7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1586\/erv.12.15","article-title":"Vaccines for hantaviruses: progress and issues","volume":"11","author":"Schmaljohn","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"R8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/(SICI)1096-9071(199608)49:4<333::AID-JMV13>3.0.CO;2-B","article-title":"Immune responses to inactivated vaccine in people naturally infected with hantaviruses","volume":"49","author":"Lu","year":"1996","journal-title":"J Med Virol"},{"key":"R9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40264-013-0039-5","article-title":"Safety of human papillomavirus vaccines: a review","volume":"36","author":"Macartney","year":"2013","journal-title":"Drug Saf"},{"key":"R10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","article-title":"Major findings and recent advances in virus-like particle (VLP)-based vaccines","volume":"34","author":"Mohsen","year":"2017","journal-title":"Semin Immunol"},{"key":"R11","first-page":"143","article-title":"Immunogenicity of Sci-B-Vac (a third-generation hepatitis B vaccine) in HIV-positive adults","volume":"19","author":"Alon","year":"2017","journal-title":"Isr Med Assoc J"},{"key":"R12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183803","article-title":"A DNA inducing VLP vaccine designed for HIV and tested in mice","volume":"12","author":"Calazans","year":"2017","journal-title":"PLoS One"},{"key":"R13","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1954","article-title":"Rotavirus virus-like particles (RV-VLPs) vaccines: an update","volume":"27","author":"Changotra","year":"2017","journal-title":"Rev Med Virol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"63488","DOI":"10.18632\/oncotarget.11329","article-title":"Construction and immunological characterization of CD40L or GM-CSF incorporated hantaan virus like particle","volume":"7","author":"Ying","year":"2016","journal-title":"Oncotarget"},{"key":"R15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/JVI.01692-06","article-title":"Incorporation of glycosylphosphatidylinositol-anchored granulocyte-macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles","volume":"81","author":"Skountzou","year":"2007","journal-title":"J Virol"},{"key":"R16","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1016\/j.vaccine.2010.03.079","article-title":"Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV","volume":"28","author":"Zhang","year":"2010","journal-title":"Vaccine"},{"key":"R17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.190.1.125","article-title":"Dendritic cells infiltrating tumors cotransduced with granulocyte\/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response","volume":"190","author":"Chiodoni","year":"1999","journal-title":"J Exp Med"},{"key":"R18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fcimb.2016.00185","article-title":"Incorporation of GM-CSF or CD40L enhances the immunogenicity of hantaan virus-like particles","volume":"6","author":"Cheng","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"R19","first-page":"1","article-title":"Laboratory biosafety manual. World Health Organization","volume":"31","year":"1995","journal-title":"Ann Ist Super Sanita"},{"key":"R20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0006-291X(02)02491-9","article-title":"The in vitro and in vivo protective activity of monoclonal antibodies directed against hantaan virus: potential application for immunotherapy and passive immunization","volume":"298","author":"Xu","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"R21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fcimb.2016.00151","article-title":"Screening and identification of an H-2Kb-restricted CTL epitope within the glycoprotein of hantaan virus","volume":"6","author":"Ma","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"R22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2016.12.001","article-title":"Recombinant DNA vaccine of hantavirus Gn and LAMP1 induced long-term immune protection in mice","volume":"138","author":"Jiang","year":"2017","journal-title":"Antiviral Res"},{"key":"R23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jmv.20643","article-title":"Characterization of truncated hantavirus nucleocapsid proteins and their application for serotyping","volume":"78","author":"Li","year":"2006","journal-title":"J Med Virol"},{"key":"R24","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/infdis\/jis475","article-title":"Hantaan virus RNA load in patients having hemorrhagic fever with renal syndrome: correlation with disease severity","volume":"207","author":"Yi","year":"2013","journal-title":"J Infect Dis"},{"key":"R25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/BC.2008.064","article-title":"The coming of age of virus-like particle vaccines","volume":"389","author":"Jennings","year":"2008","journal-title":"Biol Chem"},{"key":"R26","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/bm300590x","article-title":"Engineered mutations change the structure and stability of a virus-like particle","volume":"13","author":"Fiedler","year":"2012","journal-title":"Biomacromolecules"},{"key":"R27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2017.02.031","article-title":"Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination","volume":"251","author":"Mohsen","year":"2017","journal-title":"J Control Release"},{"key":"R28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2017.11.007","article-title":"A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice","volume":"149","author":"Cai","year":"2018","journal-title":"Antiviral Res"},{"key":"R29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004667","article-title":"Induction of long-term protective immune responses by influenza H5N1 virus-like particles","volume":"4","author":"Kang","year":"2009","journal-title":"PLoS One"},{"key":"R30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2017.04.004","article-title":"HPV vaccines - a review of the first decade","volume":"146","author":"Harper","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clim.2014.08.003","article-title":"Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens","volume":"154","author":"Landry","year":"2014","journal-title":"Clin Immunol"},{"key":"R32","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1128\/JVI.01510-12","article-title":"Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains","volume":"86","author":"Schmidt","year":"2012","journal-title":"J Virol"},{"key":"R33","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.vaccine.2016.01.031","article-title":"Long-term immunogenicity and safety of inactivated hantaan virus vaccine (Hantavax\u2122) in healthy adults","volume":"34","author":"Song","year":"2016","journal-title":"Vaccine"},{"key":"R34","first-page":"223","article-title":"A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies","volume":"18","author":"Borhani","year":"2015","journal-title":"Arch Iran Med"},{"key":"R35","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1038\/s41598-017-11803-y","article-title":"IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation","volume":"7","author":"Mitchell","year":"2017","journal-title":"Sci Rep"}],"container-title":["Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.000897?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T17:06:05Z","timestamp":1565629565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1099\/jmm.0.000897","relation":{},"ISSN":["0022-2615","1473-5644"],"issn-type":[{"value":"0022-2615","type":"print"},{"value":"1473-5644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}